News Focus
News Focus
icon url

DewDiligence

12/14/11 8:35 PM

#133072 RE: BTH #133069

Paradoxically, JPM tends to be more newsworthy for established drug/biotech companies—who often issue annual EPS guidance at the conference—than it is for development-stage companies.